Answers are grounded in this paper and cite their sources.
To the Editor. —I would like to commend Horsburgh et al1on their article entitled "Preventive Strategies in Sexually Transmitted Diseases for the Primary Care Physician" in the Aug 14 issue ofThe Journal. I would like to mention, however, that topical treatment with erythromycin and tetracycline is not definitely effective in preventing chlamydial conjunctivitis. It was interesting to note in their article that the recommendation to use erythromycin eye ointment for prevention of ophthalmia neonatorum byChlamydia trachomatisreceived the highest recommendation based on one study performed by Hammerschlag et al.2Hammerschlag and colleagues recently repeated a prospective study to evaluate erythromycin, tetracycline, and silver nitrate drops for the prevention of chlamydial conjunctivitis in a somewhat larger population than in their original study. Of 118 infants born toChlamydia-positive women, 11% who received silver nitrate, 13% who received erythromycin ointment, and 16% who received tetracycline ointment
No takes yet. Share an insight, caveat, or question.
S. M. Kegeles (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: